Ke hoʻomaka nei ʻo Dignity Health ma Arizona i ka noiʻi noiʻi mua ma ʻAmelika ʻĀkau kahi i hoʻohana ʻia ai ka hoʻāʻo genetic e ʻike ai i nā kāne a me nā wahine i ka pilikia o ka hoʻomohala ʻana i ka maʻi puʻuwai e pili ana i ke ʻano o kā lākou DNA. Inā hōʻoia maikaʻi ʻia i nā hoʻokolohua lapaʻau, hiki ke hoʻohana ʻia kēia ʻano o ka hoʻāʻo genetic ma ka honua holoʻokoʻa e pale ai i ka maʻi puʻuwai. ʻO ka maʻi puʻuwai ka mea pepehi helu 1 ma ka honua - ʻoiaʻiʻo, ʻo ka hapalua o nā ʻAmelika e manaʻo ʻia e loaʻa i hoʻokahi hanana maʻi maʻi i ko lākou ola ʻana.

I loko o ka lōʻihi o ke aʻo ʻana, e hōʻiliʻili ka hui cardiology ma Dignity Health Chandler Regional Medical Center, Mercy Gilbert Medical Center a me St. E nānā ʻia nā laʻana DNA ma Baylor College of Medicine's Human Genome Sequencing Center Clinical Lab e hoʻoholo ai inā loaʻa i nā mea komo nā hōʻailona genetic i ʻike ʻia ke kumu o ka maʻi puʻuwai.

"ʻO kēia ke kenekulia hope o ka maʻi puʻuwai," wahi a Robert Roberts, MD, Luna Hoʻokele o Cardiovascular Genomics for Dignity Health ma Arizona. "Ke manaʻolana nei au ma o nā hopena o kēia noiʻi e hiki ai iā mākou ke hoʻopakele i nā ola hou aʻe i ka wā e hiki mai ana ma o ka hoʻokō ʻana i ka hoʻāʻo genetic no ka pale ʻana i ka maʻi coronary artery ma ke ʻano he hoʻohana maʻamau."

Ke pau ka DNA genotyping, e loiloi ka hui ma nā halemai Dignity Health i Arizona i nā hōʻailona genetic o kēlā me kēia mea e hoʻoholo ai inā he haʻahaʻa, waena a kiʻekiʻe paha ko lākou hiki ke ulu i ka maʻi puʻuwai. E noʻonoʻo ʻia nā mea olakino a me ke ʻano o ka nohona i ka wā e hoʻoholo ai i ka pilikia o ka poʻe i komo i ka maʻi puʻuwai. ʻO kēia mau mea e pili ana i ka hypertension, ka maʻi diabetes, ka cholesterol kiʻekiʻe a inā ua puhi ka mea komo a i ʻole ka hana kino, a me nā mea ʻē aʻe.

E hoʻolaha ʻia nā mea noiʻi i hōʻike i ka makemake e ʻike i kā lākou hopena ma ka leka. Loaʻa i ka poʻe me ka maʻi maʻi puʻuwai kiʻekiʻe ka manawa e hui ai me nā loea cardiology a hoʻopaʻa ʻia i ka ʻōlelo aʻo genetic inā pono e pili ana i kā lākou hopena a me nā koho lapaʻau kūpono.

ʻO ka poʻe kūpono e komo i ke aʻo ʻana he mau kāne a me nā wahine ma waena o nā makahiki 40 a me 60. ʻAʻole pono lākou i ʻike i ka mōʻaukala o ka maʻi puʻuwai, ʻoiai ʻo ka pahuhopu o ka haʻawina ʻo ia ka hoʻoholo ʻana i kā lākou genetic risk no ka hoʻomohala ʻana i ka maʻi puʻuwai ma mua o ka ulu maoli ʻana.

He aha e lawe ʻia mai kēia ʻatikala:

Once the DNA genotyping is completed, the team at Dignity Health hospitals in Arizona will evaluate each participant’s genetic markers to determine if they have a low, medium or high chance of developing heart disease.
They must also have no known history of heart disease, as the goal of the study is to determine their genetic risk for developing heart disease before it actually develops.
“I am hopeful that through the results of this study we will be able to save even more lives in the future by implementing genetic testing for early prevention of coronary artery disease as routine clinical application.